Our findings report for the first time that as a target gene of miR-106a, TGFBR2 may be negatively regulated by miR-106a at the transcriptional level via binding of the 3′UTR of TGFBR2 mRNA in CRC. The gene discussed is TGFBR2; the disease is colorectal carcinoma.